SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Pictured: Amgen's office in Massachusetts/iStock,
Drug pricing
Amgen Hops on DTC Train To Offer Repatha at 60% Discount
Amgen will offer its lipid-lowering drug Repatha directly to patients for $239 per month, representing a nearly 60% reduction from the current wholesale acquisition cost of $527.70.
October 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Tariffs Anxiety and tariff stress due to economic uncertainty and trade war reciprocal taxation as global imports and exports taxed causing fear and panic in the markets.
Tariffs
Most Life Sciences Companies Not Planning New Investments After Tariffs: Report
A new survey from CRB showed that most manufacturing initiatives in the U.S. made in response to tariffs are coming from Big Pharma companies, while smaller biotechs are left to hope “the situation doesn’t get worse.”
October 7, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Business
BioSpace Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit
The inaugural 40 Under 40 cohort includes CEOs, leaders who have founded or co-founded their company and executives from a range of disciplines. Winners’ accomplishments include shaping drug development, achieving key FDA milestones and launching a new field of study.
October 7, 2025
 · 
2 min read
 · 
Angela Gabriel
Close up of set of a playing cards
Manufacturing
AMT Designation Takes First Steps Amid Uncertain Benefits
Cell and gene therapy experts question where the FDA designation fits in an environment that features a range of intersecting regulatory perks.
October 7, 2025
 · 
5 min read
 · 
Nick Paul Taylor
Pictured: CDC signage at its headquarters in Georg
CDC
CDC Adopts ACIP Recommendations on Chickenpox, COVID-19 Vaccines
A new group of CDC advisors voted last month to separate the chickenpox vaccine from the measles, mumps, rubella components of the MMRV shot due to concerns over febrile seizures, while recommending a more risk-based approach to COVID-19 immunizations that mirrors recent FDA approvals.
October 6, 2025
 · 
1 min read
 · 
Heather McKenzie
Traffic light silhouette and golden sky.
ALS
FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials
The hold was placed earlier this year when the FDA asked for more preclinical data, but the agency was slow to respond due to ‘strain’ on its capacity, according to Neurizon.
October 6, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Facade of AstraZeneca's office in Shanghai, China
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
AstraZeneca has invested heavily in AI, primarily through collaborations, including an up to $5.3 billion partnership with China’s CSPC Pharmaceutical in June.
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Manufacturing
FDA Continues US Manufacturing Drive With Domestic Generics Pilot
This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S.
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Space rocket crashed and on fire. Business failure, failed startup. Downfall of ambitious plans, flawed execution, or crisis outcomes. Volatility of startups, financial risks, or unexpected setbacks.
Gene therapy
Rocket Aborts FDA Filing for Rare Blood Disease Gene Therapy
Rocket Pharmaceuticals’ strategic realignment initiative in July pulled funding from fanca-cel, which the biotech was developing for Fanconi anemia.
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS